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To assess the impact of isoproterenol, duration of tilt, symptom
development and hemadynamlc changes on the outcome of tin
table tests, 100 patients with syncope underwent successive 80°
had up tilt for 10 min during infusions of 0, 2 and 5 lagimin of
isoproterenol. An 15 patients with another cause of syncope had a
normal test result and 66 (7890) or the 85 patients with syncope of
unknown origin had a test that resulted in syncope or presyncope.
Iseprotereml was required to produce syncope or presyncope in
X90% of poshlve tests and 66% to 80% Mr positive tests required
a date of 5 (uglmin or isoproterenol.
Without isoproerenol, symptoms did not develop until after
,a4 min
or head-up tilt. With either 2or 5 pgimtn of seproterasu,
tat half-time of symptom onset was 0.7 to 1.9 min and the rate of
symptom development did not depend m the dose of isoprotere .
mi. During syncope, the mean heart rate, systolic blood pressure
Tilt table tc^.ting holds considerable promise for the diagno-
sis of neuromediated syncope. Syncope occurs in ?3% of
adults (I) and until recently its cause could not be estab .
lishd in 50% to 85% of cases (1,2) . However, the use of
head-up tilt table testing has demonstrated that neurally
mediated bradycardia and hypotension cause presyncope or
syncope in most patients with heretafc a undiagncscd syn-
cope (3-61-
Despite the promise of this testing technique, several
factors prevent it from being generally useful in the diagnosis
of a syndrome that is not likely to be fatal (1,2) and that has
a probable prevalence ate of ?17 . Some of the current
techniques are highly invasive, utilizing intraarterial cathe-
ters and often performed after eleclrophysiologic testing (4)
or cardiac catheterization (6). The procedures used are often
lengthy because they may involve up to six graded infusions
of isoproterenol (4), each lasting up to 15 min. Tests without
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arid rate-presspre product each decreased significantly from
132 ± 21 to 67 m 25 bemslmtn, 117 a 19 to 60 a 16 mm Hg and
15 .3 ± 2
.910 4.2 t 2.2 x 10' mm Hg/tur, respectively.
During presymvpe, mean trough rate-pressure product (5 .5
2 x till mm Hg/min) was siguihrsauy higher (p = 0,027) the,
during syncope. Receiver-operating characteristic analysis
shower That a trough
rate-pressure
product <_9,000 mm Hg/mia
best separated tests ending in syncope or presyncope from asymp .
tomalic tests (positive predictive value 0 .96 to 1.0, negative
predictive value 0.91 to 0.94) regardla ; of tsoprmermd doe-
These results 1) demonstrate the need foe iseproteread to
induce syncope or prusyneepe within 5 min of bad-up tilt,
2) indicate that presyncope am be used as
.m
mtauae, and
3) define an objective ber_odyaamic outcome variable .
(J Am Call Caniw(1992,19a773-9)
isoproterenol may require 45 to t10 min of head-up tilt (3,5,7).
As well, some tests result in presyncope rather than syncope
and the diagnostic importance of this outcome is unclear,
Fiuaiiy, there is no standard against which the test can be
judged and with which the syndrome can be diagnosed .
Given these considerations, our eventual goal is to de.
velop a simple, rapid, uniform, one-stage tilt table test that
does not use intraarterial monitoring and that is
applicable
for routine clinical use. To this
end,
we evaluated the
contribution of several variables of isoproterenol-tilt table
testing to the diagnosis of syncope . Specifically, we evalu-
ated the contributions of isoproterenol infusion, duration of
head-up tilt and changes in hentodynamic variables to the
diagnostic outcome of the test
. Finally, presyncope is a
common test outcome of uncertain significance in patients
with a history of syncope because it incompletely repro-
duos clinical symptoms. To assess the hypothesis that
pre,yncope and syncope are equivalent test outcomes, we
compared the first three variables in tests that ceded in
presyncope or syncope .
Methods
Study patients. The study group consisted of 100 sequen-
tial patients referred for assessment of syncope who under-
went tilt table testing if they had previously had I) two or
more syncopal episodes, 2) one syncopal episode and fouror
more presyncopal episodes, or 3) a single episode of syncope
0735-1097,97J55.00
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causing serious injury . Patients with structural heart disease,
documented ventricular tachycardia or bifascicular block
also underwent ambulatory electrocardiography and pro-
grammed electrical stimulation with use of a previously
described protocol (8)_Tilt table tests and cleetrophysioleigic
studies were performed on separate days
. No patient under-
went tilt table testing while taking a beta-adreneceptot
blocking agent . disupyramide or a drug with antichulinergic
activity (9) . All patients gave informed consent to the
procedure .
Tilt table tests .
Patients underwent tilt table testing in a
quiet room after they had fasted for 4 to 8 h . They were
comfortably restrained on an electric till table . Instrumenta-
tion consisted of a peripheral intravenous caanula and
automatic and manual sphygmom9ornetrit blood p :cauure
cuffs . A modification of a previously described (4,6 ; tilt table
protocol was used, Initially, patients received an infusion of
5'9o dextrose in water tons min while supine, then for 10 min
in an Sn° head-up position . The test was ended if syncope
developed but otherwise proceeded to isoproterenol infu-
sion. The second stage consisted of an infusion of 2 pghnin
of isoproterenol for S min with the patient supine, followed
by a similar infusion for 5 min with the patient in the 80'
head-up position . The test was ended if syncope developed
but proceeded to the last stage in the absence of symptoms .
However, if presyncope developed in the 1st
5 min of
head-tip tilt, the 2-yvglmin isoproterenol infusion was contin-
ued until the development of syncope or to a total of 10 min .
The Last stage consisted of an infusion of 5 pglmin of
isoproterenol for 5 min with the patient supine, followed by
a similar infusion during SO" head-up tilt until the develop-
ment of syncope Or to a total of 10 min in the head-up
position . Heart rate, blood pressure and sviripturns were
recorded each minute
.
Definitions, Syncope was defined as a transient state of
unconsciousness characterized by spontaneous recovery or
recovery in the supine position. Presyncope was defined as a
state of light-headedness that substantially reproduced the
clinical presyncope of the patient and was usually associated
with one or more symptoms of decreased vision, the sensa-
tion of heari,tg voices distantly, slow response times to
verbal stimuli, nausea, vomiting or partial loss of postural
cone. Isolatedpreryncope was defined as a subset of presyn-
cope than did not lead to syncope during the stage of the tilt
table test in which it developed .
Statistics . Results are expressed as mean valoat I ND,
One-way analysis of variance was used to compare the
differences between multiple groups. Student r tests (paired
or unpaired) were used to compare differences between pairs
of groups . The correlation of continuous variables between
groups was determined by linear regression analysis . The
null hypothesis was rejected at a level of p < 0,05 . Receiver-
operating characteristic analysis was performed as descnoed
by Metz (10)
.
Table L, Clinical Charncerstics of 85 Patients With Syncope of
Unknown Origin Undergoing Tilt Table Testing
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^Plcsynmpe Vs. syncope . P a 0 .02: negative vs . syncope, p A 0.001 .
Results
Clinical characteristics (Table 1). Of the 100 patients with
syncope who underwent tilt table testing, 66 had a test that
ended in presyncope or syncope . Of these tests, 41 ended in
syncope and 25 in presyncope . Patients with a normal test
result tended to be older (53 ± 17 years) than patients with
presyncope (45 ± 22 years) and were significantly older than
patients with syncope (34 ± 1S years). The groups had a
similar gender distribution and a similar number of syncopal
episodes. The mean ± SD and median number of syncopal
episodes reflect the fact that although a few patients had a
very large number of syncopal episodes, 50% of the patients
had five or fewer episodes. Patients in all three groups had a
similar duration of symptoms. Thus, the only significant
difference between the groups was age, patients with a
normal test result being significantly older than patients with
a test ending in syncope (p < 0
.001) .
Diagnostic a«uracy . Determining the specificity of this
tilt table test was not a goal of the study protocol, However .
none of the IS patients with syncope due to other known
causes (inducible ventricular tachycardia in 4, carotid sinus
syndrome in 3, His-Purkinje disease in 3, cough syncope in
I, beta-adrenargic blacker overdose in 1, sinus arrest in 1,
rapid retrial fibrillation in I and epilepsy in 1) had
a test that
resulted in clinically relevant presyncope or syncope . Of the
85 patients with syncope of unknown origin, 66 had a test
ending in presyncope or syncope. Thus, the apparent yield
of this protocol in the diagnosis of syncope of unknown
origin is 78% and no patient with syncope due to other
ceases had a positive tilt test result .
Cuntribulfou of each stage to symptomatic outcome (Tables
2 and 3). Our eventual goal is to develop a tilt test that uses
a single Infusion of isoproterenol. Therefore, the relative
diagnostic contributions of each of the three isoproterenol
doses (none and 2 and 5 pglmin) were assessed with four
measures : the first stage during which symptoms developed,
the stage during which syncope occurred, the last sympto-
matic stage of the test and the time dependence of symptom
'rest Outcome
Syncope (ANO0A)Neretive Presyncope
9o. 19 25 41
YLMaz 37 ;2 45
A8n hrl 53 t 17 45 * 22 34 t I8 <O .mP
synecpt episodes Inc .)
312 t_ 1,208 95 t_ 325 NSW., ± So 262 ' 1.027
Mcdiw 6 17
88 n 124
5
49 C 77 NS
ounlinn
or symptoms on
.)
steer !
So
SE s 145
Median 21 24 18
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Table 2 . Contribution of Each tsoproternol Uose to Diagnoslic
Outcome in 66 Patients With Syncope or Presvncope On Tilt
Table Testing
development with and without isoproterenol (Table 2 . Fig .
1) . First, symptoms of presyncope or syncope occmled in
only 5 (8%) of 66 patients in the absence of isoproterenol and
in only 17 (26%) of 66 patients given 2 µglmin of isoproter-
enol. In 44 (67%) of the 66 tests that ended in presyncope or
syncope, the patient first developed symptoms during a
5-µglmin infusion of isoproterenol . demonstrating the impor-
tance of this dose in eliciting symptoms.
Second, we determined the number of patients at each
stage who developed syncope . Among 41 patients whose test
ended in syncope, syncope occurred in the absence of
isoproterenol in 4 and during the 2-µglmin infusion of
isoproterenol in 9
. The other 28 patients (68%I developed
syncope with 5 µglmin of isoprotterenol, demonstrating the
importance of ibis dose of isoproterenol in eliciting syncope .
Third, we determined the incidence of each stage at
which a diagnosricallypositive test ended. By design, the tilt
table test could not be ended as a result of presyncope that
occurred in the absence of isoproterenol or in the presence
of only 2 µglmin of isoproterenol . Tests were allowed to end
when presyncope occurred only if the patient had received
5 µglmin of iisoprolerenol for a 19-min head-up tilt. Of 66
tests ending in presyncope or syncope, 416%) ended with
syncope in the absence of isoproterenol, 9 (14%) ended in
the presence of 2 µglmin of isoproterenol and 53 (80%) ended
in the presence of 5 µgmin of isoproterenol,
SHEI-DON AND KILLAM
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Finally . itr compared the rare of development of presyn-
rapr in 57 patients who developed presyncope or syncope
either without isoproterenol (n = 51 or with 5 *min of
isoproterenol (n = 52)
. During the Ist 5 min of head-up till,
only I porient developed presyncope without isoproterenol,
whereas 50 (96%) of 52 patients who developed symptoms
with 5 1gimin of isoproterenol did so within 5 min of
assuming the head-up position . presyncope in this group
developed without a lag (Fig . IA) and reached a plateau with
a time course that was fit by a rnonoexpnnential equation
1r = -0.98) (Table 3) .
Thus, head-up
till ,rith
an infusion of
5 µglmin of isvpro-
rerenof makes the greatest eaeuribarion to a positive ie>t,
whether this is assessed at the stage during which symptoms
first occurred (66%)
. the stage during which syncope oo-
cotred
16"? : xthu stage at whiclahe test ended i80fk) orb,
the time dependence of symptom development.
Duration of head-tip did and symptom develotmtenl. The
monocxponenlial time course for the development of pre-
syncope (Fig. 1) has avo potential implications for the
development of a till test with single infusion of isoprotcr-
enol . First . it suggests that the effect of various doses of
isoproterenol on the rate of symptom development could be
determined by comparing the half-times of symptom onset
during these different infusions of isoproterenol . Second, it
affords the opportunity to optimize the duration of head-up
tilt to yield a maximal number of positive tests with a
minimal duration of tilt .
Figure I shows the time course of symptom development
in the 52 patients who were symptomatic during head-up tilt
,,ilk
ore
infirriv t of 5 µglmin of isaprorervuel . The rate of
symptom development is displayed for four groups of pa-
tients (28 patients with presyncope that was followed by
syncope. Z4 pttients with isolated presyncope, all 52 symp-
tomatic palLats with presyncope and 28 patients with syn-
cope) . All symptoms developed with an apparent mottoex-
ponential time course . Syncope developed with a half-time
of 1 .9 min, including an apparent lag of0.7 min . P- esyncope
in the entire study group followed an apparent monoexpo-
Table 3. Time•Uepeedence of Symptom Development During : Isopeutcrenol Infusion 1152 Patients
The time depemyencr of symptom develolxnent dieting icopmteronnl inf .san and head .ap till are demised from
the dam petsenled in Fitan: I sad other related dam . lhe camlation Caealeienl In describes lie
61 of the rdevmn
d. . to a linear regrdson analysB of,he swan on a= all - e - 't, where a aepresents be nam6erof cymploimtic
patients, a represents the trial number of patinas and t represents he duntion of head-up tilt in minutes . Curves
wore not forced to pass iii-0 the origin x = d.
t = 0 . The half-time
required
for dcvdopment or symptoms ie
susceptible patients is also delved from Ibis equation.
Isoprmereitet.2pplmin Impaulereral.5patmin
Sym(eun Nn . rValue
Half-Time to
SteM 01005 51151
No . "value
H l-liine 10
Sympt000lmi'o
Persynenpeif 9 -0.9d 10 26 -0.99 0.7
rymaps 0115101
Synsnpe 9 -0 .97 2h -0.95 1 .6
Itotaledpresyneope 8 -O .SO 24 -0.96 1 .5
All presyncope 17 -0.97 52 -9.% 1 .2
tsnSmtvauolDoso
(p®'m3r.1
FoalOo,ct
or 6 ymptr.ma
0"o" =t-
orSyrcope
LI,!
Dlapoostr
Stare
Na . % No . `E No
0 5 8 4 10 4 6
2 17 26 9 2'- 9 N
5 44 67 28 68 50 re
Total 66 100 It an 66
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Time. min
nentiat curve with a half-time of 1 .2 min, although this curve
was composed of the curves of two subgroups : one with
isolated presyncope (half-time 1-5 min) and another with
presyncope followed by syncope (half-time 0 .7 min) . In
these subgroups, the onset of symptom development during
an infusion of 2 pg/min of Isoproterenol followed a similar
time course (data act shown) and is summarized in Table 3 .
The fit of the time course of symptom development to
monoexponential curves facilitates comparisons of both the
dependence of symptom development on isoproterenol dose
and the rate of development of symptoms in the various
groups (Table 3). For example, in patients who develop
syncope, the rate of onset of presyncope is similar during
both 2 µglmin (half-time I min) and 5 pg/min (half-time
0.7 min) of isoproterenol . Similarly . isolated presyncope
develoc more slowly than does presyncope that progresses
to syncope, whether this is assessed during infusion of
2 pg/min (half-time I .0 vs . I min) or 5 pg/min (half-time 1 .5
vs. 0.7 min) of isoproterenol .
Hemodynomlc cnmparlsen or syncnpe and Isolated presyn-
cope (Table 4). Heart rate, systolic blood pressure and
rate-pressure product each decreased markedly and signifi-
cantly in tests ending in syncope or in isolated presyncope in
the presence of 5 µg/min of isoproterenol, but not in tests
ending asymptomatically . Compared with tests ending in
syncope, those ending in presyncope were characterized by
a significantly smaller decrease in heart rate (syncope vs .
presyncope, p = 0 .01) and rate-pressure product (syncope
vs . presyncope, p = 0.027) . Thus, the presyncopal state is
associated with hemodynamic changes that are slightly but
significantly less disturbed than those in the syncopal state .
These data support the use of presyncope that is similar to
the patient's clinical presyncope as a test outcome, but
-4.0
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Figure 1 . Time curse of the onset of symptoms
during head-up till with infusion of 5 pg/mia of
isoproterenol . In the lalltom panels, curves are fit
to the data with the monuexponential equation
•
d
•
escribed in Table 4 . Ln = natural logarithm
.
suggest the potential usefulness of objective hemodynamic
outcome variables .
Hemodynamk measures of test outcome. To develop
ob-
jective
hemodynamic measures that would serve as dichot-
omous values to classify test outcome as normal or abnor-
mal . we first compared the reductions in heart rate, systolic
blood pressure and rate-pressure product between patients
with asymptomatic tests and patients who developed frank
syncope while receiving 5 Ag/min of isopreterenol (Fig- 2)_
There were marked and significant differences in the distri-
butions of all three variables between the 28 tests ending in
syncope and the 34 tests ending asymptomatically . These
data suggest that dichotomous values for trough heart rate,
systolic bland pressure and rate-pressure product might
discriminate between tests ending without symptoms or with
cyn vpe . Accordingly, receiver-operating characteristic
analysis (10) of these three measures was performed . A
negative test was defined as one with neither presyncope nor
syncope and a positive test as one ending in syncope during
an infusion of 5 )eg/min of isoproterenol .
The sensitivity and specificity of various trough heart
rates, systolic blood pressures and rate-pressure products
were determined and the results of conventional receiver-
operating characteristic analysis are shown in Figure 3A .
The trough rate-pressure product appears to best discrimi-
nate between tests ending with syncope and tests ending
without symptoms .
To determine whether this finding is applicable to other
test conditions and outcomes, we performed a similar
receiver-operating characteristic analysis in which positive
tests were defined as those ending in isolated presyncope
during infusion of 5 µg/min of isoproterenol (Fig . 3B), tests
ending in either syncope or isolated presyncope with
A
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5 pg/min of isoproterenol (Fig . 30 and tests resulting in
either syncope or isolated presyncope with 2 pglmin of
isoproterenol (Fig
. 3D) . The trough rate-pressure product
best discriminated between negative and positive test re-
sults, regardless of which symptom was defined prospec-
lively as positive . The, data in Table 5 demonstrate the high
positive and negative predictive values (0 .91 to I-0) of a
trough rate-pressure product _019,000 mm Hglmin .
Discussion
The principal conclusions of
this study are that I) an
infusion of 5 pglmin of isoproterenol is required for symptom
devclopmeut or diagnosis ire 667 to 1 :10 of tests, depending
on when the test isjudgetl to be positive.?) a head-up lilt test
lasting only 5 min is sufficient to induce symptoms in 95% of
a susceptible group of patients
; 31 a decrease in rate-pressure
product to o9,000 mm Hg/min accurately identifies both
normal and abnormal test results ; and 41 isolated presyncope
resembles syncope, although the decrease in heart rate and
rate-pressure product is significantly less severe . These
results suggest the possibility of performing a very brief tilt
table test with a single infusion of isoproterenol-
Diugnostic outcome of tilt table tests. The diagnostic char-
acteristics of our tilt table protocol are similar to those
of
others, indicating that an exploration of tilt test variables
with this protocol should be relevant and applicable . The
proportion of positive tests in syncopal patients in this study
(78%) compares well with the proportion of positive tests in
similar patients in other studies, whether isoproterenol was
infused (as in the studies of Waxman et al . [61, 7356 :
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Figure 2. Heart rate- systolic blood pressure and role-pressure
product during head-up tilt with i pg1min of isoproterenol . The
hemodynamic values oc red during syncope in tests with a
positive result or after 10 min of head-up tilt in tests with a negative
result.
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Figure 3 . Receiver-operating characteristic analysis of trough heart
rate (0), systolic blood pressure (0) and rile-pressure product (U
as diehotomoos hemodynamic variables. The data are from analyses
lar to those of Figure 2 . The symptoms against which these
variables were tested were syncope during 5 tagimin of isoproterenol
(A), isolated presyncope during 5 pgrmin of isoproterenol (B),
isolated presyncope and syncope during 5 ugimin of isoproterenol
(C) and isolated presyncope and syncope during 2 pgimtn of
isupretererlol (D). Sensitivity and specificity are expressed in per-
cert as is 190 ndnus specificity,
Pongiglione et al . [ i ll . BO% ; Almquist el al .
[4] .
87%) in
whether isoproterenol was not used (as in the studies of
Fiszpatrick and Sutton [12], 74% ; Abi-Samra ct al. 13], 63%
;
Strasberg et al, [13], 3g%a). Similarly, the lack of ability to
induce clinically relevant symptoms in all 15 patients with
other causes of syncope compares well with the 95% to 100%
specificity reported by others However, several
factors might influence the apparent specificity of these test
protocols . For example, the degree of intravascular instru-
mentation Fibers; the specificity of the test, Stevens (14!
Tame 5- Predictive Values of s tccrcase in Ratc-Pressure
Product to v9,tlOa mm Hg/min
The position
and negative predictions inesofadecreaseioralopnoasore
prod- In 0_9,000 mm Hgtmin for lasts ending in syncope ar isotalnd
presyncope, or both, during isopmtererol infusion are paesesrted . Patients
wlnse blood pressure was tae low to be recorded In -
4 du ring syncope wah
5 pglmin
of isopraterenott ere not included in this analysis .
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showed that 52% of 51 asymptomatic subjects became
syncopal when head-up till table testing was conducted with
immaterial monitoring, but only 9% of 223 asymptomatic
subjects became syncopal during tilt table testing without
intravascular monitoring . In addition, tilt table specificity
may be related to age (15). Selecting patients in a predomi-
nantly older population as normal control subjects may
overestimate the specificity of a protocol .
Evaluation of lilt table test condilions . The primary goal of
this work was to assess some of the variables of the till table
test that elicit a positive test outcome, both to better
understand the technique sod to define the conditions for a
briefer single-infusion test . First, en isoproterenol infusion
was necessary to produce a positive outcome in 90% to 92%
of tests ending in either syncope or presyncope . This obser-
vation is in contrast to the data of Johnson et al
. (16), who
found that about 40% of patients who fainted during their
study protocol did so in the absence of isoproterenol. It may
be noteworthy that the tilt tests in that study (16) were
dated with intraartenal cannulation . The role of isopro-
terenol in eliciting syncope is unknown ; Waxman et al . (6)
proposed that it increases contractility . thereby increasing
left ventricular baroreceptor discharge .
Second, die monoexponentiial time course of the onset of
syrnproms Irish isoproterenol infusion allows an estimate of
the optimal
duration of the infusion
.
A head-up tilt with any
effective dose of isoproterenol should elicit symptoms in
95% of susceptible patients within 5 min, and much longer
tilts are clearly unnecessary .
T7urd, objective hemodynamic outcome variables were
evaluated. These are necessary given the occasional uncer-
tainty of the significance of
isolated presyncope as a test
outcome. A decrease in the rate-pressure product to
09,900 mm Hg'min x IOa accurately identified 96% to 100%
of positive tests and 91% to 94% of negative tests whether
syncope or presyncope was the symptomatic end point and
regardless of isoproierenol dose . A potential limitation of
use of this variable is that trough blood pressure could not be
recorded to 4 DI 41 tests ending with syncope and heart rate
data were not obtained in I of 41 tests ending with syncope .
None of these Inst data occurred in patients without syn-
cope . indicating that this measurement could be used in
patients with presyncope or equivocal outcomes
. The use of
this variable has the advantage of assessing the decrease in
both heart rate and blood pressure that characterizes neuro-
mediated syncope (3-6).
Isolated presyncope as a test outcome, Finally, we as-
sessed presyncope as a clinical outcome of the test, Our
results show that isolated presyncope develops at a rate
similar to that of syncope but is associated with slightly but
significantly less profound decreases in heart rate and rate-
pressure product . However, patients with isolated presyn-
cope have values for heart rate, blood pressure and rate-
pressure product below the diagnostic dichotomous values
derived for syncope
. Finally, the test reproduces the pa-
tient's particular symptoms of clinical presyncope
. Thus,
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presyricope and syncope have similar time courses and
hemodynamic changes and both substantially reproduce the
patient's clinical symptoms . Both appear to reflect the same
pathophysiologic changes, but it is unknown whether then
have the same prognostic value .
Limitatiwts. This study has several limitutions . First . the
limitations of test mechanics and patient selection Steve been
discussed . Second, it may be that the results of infusing
5 aglmin of isoproterenol are biased because of tachyphy-
laxis due to the preceding lower dose infusion . This study
does not address this concern, which is the subject of
ongoing work . Third, the reproducibility of this protocol is
not addressed here . Previous data
(17)
have shown that the
overall reproducibility is 79% tee 91Mk. Finally . There is no
reference standard for judging tilt table tests. Neuromedi-
sled syncope is diagnosed as a symptomatic outcome on a
tilt table test, but the specificity of the test has not beer
defined in a large number of asymptomalic patients, nor has
the sensitivity been defined in patients with documented
hypetension or bradycardia, or both, occurring sponlane.
ously . However, our work indicates the feasibility of a
single-stage tilt table test that would facilitate the study of
both the specificity of the test and the pathophysiologic
changes occurring during the test .
We thash Dane Manyari . MD and Henry Duff. MD for constructive com-
ments and Dianne Swinton for expert help with the manuscript .
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